[TA90--new neoplastic marker]

Pol Merkur Lekarski. 2010 Mar;28(165):211-3.
[Article in Polish]

Abstract

TA90 is a glycoprotein, occurring on the cell surface of many types of cancer. Determination of its concentration in human serum appears to be a good screening test in the direction of many cancers, and also can act as a monitoring index of disease, particularly in respect of melanoma. Further clinical studies are necessary in order to obtain accurate data on the TA90, and after that its determination might be made to everyday clinical practice in oncology.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antigens, Neoplasm / blood*
  • Biomarkers, Tumor / blood*
  • Colonic Neoplasms / blood*
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / therapy
  • Humans
  • Immunotherapy
  • Melanoma / blood*
  • Melanoma / diagnosis
  • Melanoma / therapy
  • Pancreatic Neoplasms / blood*
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / therapy
  • Skin Neoplasms / blood*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / therapy

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • TA90 immune complex